Oxitone Medical Receives FDA Clearance

MHW has learned that Oxitone Medical (Oxitone), an Israeli-based medical device and digital health company developing wearable monitoring solutions to transform delivery of chronic disease home care, has received 510(k) clearance from the FDA for its wrist-sensor pulse oximetry bracelet Oxitone 1000.

More than 20 million Americans suffer from cardio-pulmonary chronic diseases that cause more than 420,000 deaths a year, and these numbers are growing.

The wrist-sensor pulse oximeter Oxitone 1000 measures critical vital signs such as SpO2 and pulse rate with the same precision as conventional fingertip pulse oximeters.

Oxitone 1000 becomes the first to market a wrist-sensor pulse oximeter that offers comfortable real-time monitoring with high patient compliance.

“The Oxitone transformative solution redefines the way measurements happen. We shift a care paradigm towards unification of hospital and home care of chronic diseases,” said Oxitone Founder and CEO Leon Eisen, PhD.

This post was written by:

- who has written 371 posts on mHealthWatch.

Contact the author